Table 2.
F/M | 847/186 (81.99%) |
Age at diagnosis (SD) | 46.79 ± 14.62 |
Age at anti-TNF start, years (SD) | 55.12 ± 13.4 |
Disease duration, years (SD) | 7.68 ± 8.15 |
Comorbidities | 704/1033 (68.15%) |
F: female; M: male; SD: standard deviation.
F/M | 847/186 (81.99%) |
Age at diagnosis (SD) | 46.79 ± 14.62 |
Age at anti-TNF start, years (SD) | 55.12 ± 13.4 |
Disease duration, years (SD) | 7.68 ± 8.15 |
Comorbidities | 704/1033 (68.15%) |
F: female; M: male; SD: standard deviation.